110 related articles for article (PubMed ID: 30816497)
21. Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.
Franke NE; Kaspers GL; Assaraf YG; van Meerloo J; Niewerth D; Kessler FL; Poddighe PJ; Kole J; Smeets SJ; Ylstra B; Bi C; Chng WJ; Horton TM; Menezes RX; Musters RJ; Zweegman S; Jansen G; Cloos J
Oncotarget; 2016 Nov; 7(46):74779-74796. PubMed ID: 27542283
[TBL] [Abstract][Full Text] [Related]
22. Membrane proteome analysis of glioblastoma cell invasion.
Mallawaaratchy DM; Buckland ME; McDonald KL; Li CC; Ly L; Sykes EK; Christopherson RI; Kaufman KL
J Neuropathol Exp Neurol; 2015 May; 74(5):425-41. PubMed ID: 25853691
[TBL] [Abstract][Full Text] [Related]
23. EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.
Misek SA; Chen J; Schroeder L; Rattanasinchai C; Sample A; Sarkaria JN; Gallo KA
Mol Cancer Res; 2017 Aug; 15(8):1085-1095. PubMed ID: 28487380
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
25. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
27. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
[TBL] [Abstract][Full Text] [Related]
28. MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
Manai M; Abdeljaoued S; Goucha A; Adouni O; Bettaieb I; Bouzaien H; Rahal K; Birnbaum D; Bertucci F; Gamoudi A
Cancer Biomark; 2019; 26(4):513-522. PubMed ID: 31771045
[TBL] [Abstract][Full Text] [Related]
29. Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers.
Fong LWR; Yang DC; Chen CH
Cancer Metastasis Rev; 2017 Dec; 36(4):737-747. PubMed ID: 29039083
[TBL] [Abstract][Full Text] [Related]
30. Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
Bo H; Fan L; Gong Z; Liu Z; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Cao K; Zhang S; Xiong F
Oncol Rep; 2019 Apr; 41(4):2431-2439. PubMed ID: 30816545
[TBL] [Abstract][Full Text] [Related]
31. DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation.
Ma YS; Wu ZJ; Bai RZ; Dong H; Xie BX; Wu XH; Hang XS; Liu AN; Jiang XH; Wang GR; Jiang JJ; Xu WH; Chen XP; Tan GH; Fu D; Liu JB; Liu Q
Cancer Lett; 2018 Jun; 423():86-94. PubMed ID: 29548818
[TBL] [Abstract][Full Text] [Related]
32. Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo.
Rombouts K; Carloni V; Mello T; Omenetti S; Galastri S; Madiai S; Galli A; Pinzani M
Cancer Lett; 2013 Jun; 333(2):244-52. PubMed ID: 23376641
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
[TBL] [Abstract][Full Text] [Related]
35. MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.
Lu Y; Xiao L; Liu Y; Wang H; Li H; Zhou Q; Pan J; Lei B; Huang A; Qi S
Autophagy; 2015; 11(12):2213-32. PubMed ID: 26553592
[TBL] [Abstract][Full Text] [Related]
36. MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.
Liu J; Chen SJ; Hsu SW; Zhang J; Li JM; Yang DC; Gu S; Pinkerton KE; Chen CH
Theranostics; 2021; 11(9):4122-4136. PubMed ID: 33754052
[No Abstract] [Full Text] [Related]
37. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma.
Chang L; Zhao D; Liu HB; Wang QS; Zhang P; Li CL; Du WZ; Wang HJ; Liu X; Zhang ZR; Jiang CL
Mol Med Rep; 2015 Nov; 12(5):6702-10. PubMed ID: 26299938
[TBL] [Abstract][Full Text] [Related]
38. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
40. MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
Yang Z; Xu S; Jin P; Yang X; Li X; Wan D; Zhang T; Long S; Wei X; Chen G; Meng L; Liu D; Fang Y; Chen P; Ma D; Gao Q
Oncotarget; 2016 Jun; 7(25):37649-37663. PubMed ID: 27081703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
